BAY-204
BAY-204 (BRD3727) is a potent, ATP-competitive, and selective CSNK1α inhibitor (IC50 = 2 nM at 10 μM ATP; 12 nM at 1 mM ATP) . BAY-204 can be used for the study of acute myeloid leukemia (AML) [1][2].
Product Specifications
CAS Number
2468784-57-6
Product Name Alternative
BRD3727
UNSPSC
12352005
Target
Casein Kinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bay-204.html
Purity
99.94
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C2=C(NC(C3=CC=NC(NC([C@@H](CC(F)F)C4=CC=C(F)C=C4)=O)=C3)=C2NC5=CC=CC=C5)CCN1C
Molecular Formula
C29H26F3N5O2
Molecular Weight
533.54
References & Citations
[1]Volker Schulze, et al. 3-amino-2-[2- (acylamino) pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as csnk1 inhibitors. WO2020161257 A1. |[2]Steven M. Corsello, et al. Abstract 3588: Discovery of potent and selective CSNK1A1 inhibitors for solid tumor therapy.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CK1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA368245 100 µL
Epithelial Stromal Interaction 1 (EPSTI1) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details